![](https://i0.wp.com/macmodule.com/wp-content/uploads/2021/11/Our-Story.jpg?resize=1190%2C397&ssl=1)
Meet Our Team
![](https://i0.wp.com/macmodule.com/wp-content/uploads/2024/06/Tariq.jpg?resize=1024%2C1024&ssl=1)
Tariq Chaudry, MD
Inventor, Founder of Inventeur, LLC
![](https://i0.wp.com/macmodule.com/wp-content/uploads/2024/07/Rschumann-2017.jpg?resize=1024%2C1024&ssl=1)
Roman Schumann, MD
Professor, Anesthesiology
![](https://i0.wp.com/macmodule.com/wp-content/uploads/2024/06/Juan-Valdivia-1.jpg?resize=914%2C914&ssl=1)
Juan Valdivia, MD
Neurosurgeon
![](https://i0.wp.com/macmodule.com/wp-content/uploads/2024/06/unnamed-1.jpg?resize=425%2C425&ssl=1)
Raymond Vennare
CEO, Inventeur, LLC
![](https://i0.wp.com/macmodule.com/wp-content/uploads/2024/06/Andy-M.jpg?resize=400%2C400&ssl=1)
Andrew McCutchen
Engineer, President and CEO, Baymar Solutions
![](https://i0.wp.com/macmodule.com/wp-content/uploads/2024/06/Petney-1.jpg?resize=673%2C673&ssl=1)
Matthew Petney
Project Engineer, Baymar Solutions
![](https://i0.wp.com/macmodule.com/wp-content/uploads/2024/06/JenniferMorrisBWHeadshot-1.jpeg?resize=1024%2C1024&ssl=1)
Jennifer Morris, SHRM-CP
Marketing and Business Support
![](https://i0.wp.com/macmodule.com/wp-content/uploads/2024/07/Paul_Dryden-transformed.jpeg?resize=800%2C800&ssl=1)
Paul Dryden
FDA Regulatory, President, ProMedic LLC
![](https://i0.wp.com/macmodule.com/wp-content/uploads/2024/07/D._Piper-transformed.jpeg?resize=400%2C400&ssl=1)
Dave Piper
President and CEO, Piper Medical
Our Story
Behind the Invention
Inventeur, LLC was formed specifically to develop the Anesthesia Intra-oral Module. This device was invented by a practicing anesthesiologist who witnessed the limitations and shortcomings of devices currently in use. AIM is a patent-protected, FDA-designated Class II, 510(k) device.
The AIM was one of the few devices selected and invited for a presentation at the Annual Meeting of the Society for Technology in Anesthesia (a global conference of anesthesia innovators) in Austin, Texas, in 2020.
The Inventeur team includes highly experienced anesthesiologists and business professionals with deep experience in biotechnology and technology commercialization.
The company has made significant progress in a short period. The device is currently under review by the FDA for clearance.
The company believes that anesthesia providers and non-operating room anesthesia (NORA) physicians will understand the value of a device that measurably improves patient monitoring, enhances patient safety, reduces hospital stays, and engenders patient satisfaction.